SSY Group (HKG:2005) said it won a bid to supply 12 medicines to government-linked healthcare facilities in China, according to a Hong Kong bourse filing Tuesday.
The company had submitted tenders for 14 medicines, of which it won 12, namely diprophylline injection, formoterol fumarate inhalation solution, fluvoxamine maleate tablets, lornoxicam for injection, epinephrine hydrochloride injection, bromhexine hydrochloride injection, multiple electrolyte injection, multiple electrolyte injection (II), nicorandil tablets, salbutamol sulfate injection, benidipine hydrochloride tablets, and sodium bicarbonate injection.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments